intelliatx.com - Kapitalisasi Buku NTLA

Logo perusahaan publik intelliatx.com (NTLA)

Intellia Therapeutics (NTLA) focuses on genome research by outsourcing production and testing to third-party contractors, as confirmed by this price action chart. The company is diversifying its portfolio by developing methods to correct pathologies both in vivo and ex vivo. Despite support from industry behemoths, high R&D costs and the risk of side effects keep the indicator at 0.73.

intelliatx.com (NTLA) - Nilai Buku Perusahaan saka 04.07.2022 nganti 28.10.2026

Intellia Therapeutics, Inc. (NTLA) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Bagan rega Intellia Corp|NTLA - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar Intellia Therapeutics Inc|NTLA - Nilai Perusahaan
- data kapitalisasi buku:
Ekuitas saben Saham Intellia Therapeutics|NTLA - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku intelliatx.com|NTLA - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Intellia Therapeutics|NTLA - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Intellia Therapeutics Inc|NTLA - Utang perusahaan|Rasio utang marang nilai buku Intellia Therapeutics Inc|NTLA - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Intellia Therapeutics
Analisis dhasar perusahaan:Intellia Therapeutics
Produk seri Intellia

High R&D expenditures at Intellia Therapeutics (NTLA) and stringent FDA oversight necessitate significant financial reserves. This metric is calculated as the difference between all assets and liabilities, determining the actual value of net equity. An increase in this value confirms the company's resilience against bankruptcy during prolonged clinical trials. It is critical for investors to monitor the balance between liquidity and capital efficiency. Analyzing the balance sheet capitalization allows for a real-time assessment of investment security.

Pesaing Intellia Therapeutics (NTLA)

TEM - Nilai Buku Perusahaan|QGEN: Kapitalisasi Buku|ionispharma.com (IONS) - Kapitalisasi Buku|Kapitalisasi Buku Repligen (RGEN)|Kapitalisasi Akuntansi RNA|Nilai Buku Perusahaan CRISPR Therapeutics Corp CRSP|Kapitalisasi Akuntansi GeneDx Corp (WGS)|Kapitalisasi Buku RARE (Ultragenyx Pharmaceutical)|Kapitalisasi Buku beamtx.com BEAM|Kapitalisasi Buku SRPT (Sarepta)|TWST: Pambiji Buku Bisnis|Nilai Buku Perusahaan 10x Genomics Corp|Kapitalisasi Akuntansi Stoke Corp|BioLife Solutions, Inc. (BLFS) - Aset Bersih Perusahaan|Total Aset Bersih wavelifesciences.com|Maze Therapeutics - Kapitalisasi Buku|Ekuitas Perusahaan SION (Sionna Therapeutics, Inc.)|Nilai Buku Perusahaan Prime Medicine Corp PRME|Taysha Corp - Nilai Buku Perusahaan|QURE - Nilai Buku Perusahaan|MGTX - Nilai Buku Perusahaan|REGENXBIO - Kapitalisasi Buku|Solid Biosciences Inc (SLDB) - Pambiji Buku Bisnis|OCGN (Ocugen Corp) - Kapitalisasi Buku|Kapitalisasi Buku PacBio Corp (PACB)|Benitec Biopharma Inc. (BNTC) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan designtx.com DSGN|Aset Bersih Perusahaan Rocket Pharmaceuticals, Inc. (RCKT)|Total Aset Bersih 4DMT FDMT|Kapitalisasi Buku Lexeo (LXEO)|KRRO - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EDIT|SLN (silence-therapeutics.com) - Ekuitas Perusahaan|PRQR - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan Codexis Bio|Kapitalisasi Buku SGMO|Kapitalisasi Buku NAUT (nautilus.bio)|Metagenomi, Inc. (MGX) - Nilai Buku Perusahaan|Nilai Aset Bersih Precision BioSciences Inc. DTIL|GBIO (Generation Bio Corp) - Kapitalisasi Buku|Boundless Bio Inc. (BOLD) - Ekuitas Perusahaan|XCUR: Aset Bersih Perusahaan|Kapitalisasi Buku Imunon|Phio Pharmaceuticals Corp (PHIO) - Aset Bersih Perusahaan|Total Aset Bersih Mustang Bio Corp|RNAZ (TransCode Therapeutics) - Kapitalisasi Buku|Pambiji Buku Bisnis bionanogenomics.com (BNGO)|Applied DNA - Kapitalisasi Buku|bluebird bio, Inc - Aset Bersih Perusahaan|Nilai Buku Perusahaan IPA (ImmunoPrecise)|OMGA: Pambiji Buku Bisnis|Nilai Buku Perusahaan Singular Genomics|Kapitalisasi Akuntansi Regulus Therapeutics, Inc.|Syros (SYRS) - Aset Bersih Perusahaan|Total Aset Bersih TBIO|Nilai Buku Perusahaan TRACON Pharmaceuticals (TCON)|Nilai Buku Perusahaan unitybiotechnology.com (UBX)